• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Proactive news headlines including Victory Square Technologies,Talon Metals, Soma Gold and Champignon Brands

    2/4/21 11:13:00 AM ET
    $NMRD
    Medical/Dental Instruments
    Health Care
    Get the next $NMRD alert in real time by email

    New York , Feb. 04, 2021 (GLOBE NEWSWIRE) -- Victory Square Technologies (CSE:VST) (OTCMKTS:VSQTF) completes acquisition of mobile health provider IV Hydreight in US$1.6 million deal click here

    Ceylon Graphite Corp (CVE:CYL) (OTCMKTS:CYLYF) (FRA:CCY) scales up drill program at H1 site in Sri Lanka click here

    Predictmedix Inc (CSE:PMED) (OTCQB:PMEDF)  to deploy its Safe Entry Stations at this weekend's Super Bowl festivities in Tampa click here

    Loop Insights Inc (CVE:MTRX) (OTCQBRACMF) enters first pure e-commerce pilot with leading UK online electronics retailer click here

    Talon Metals Corp (TSE:TLO) (OTCMKTS:TLOFF) (FRA:TAO) hails latest PEA on giant US nickel project, which shows robust economics click here

    GSRX Industries Inc (OTCPINK:GSRX) to open 'virtual delivery only restaurant' in State College, Pennsylvania next month click here

    O3 Mining Inc (CVE:OIII) (OTCMKTS:OQMGF) makes new gold discovery at Golden Bridge area of Marban project, which could become new open pit resource click here

    Soma Gold Corp (CVE:SOMA) (OTCMKTS:PRSRF) sees potential for stronger economics after Cordero-Balvina mine project drilling click here

    LeanLife Health Inc (CSE:LLP) (OTCPINK:LHLNF) (FRA:LL1)  inks management consulting deal with Big Venture Sales to start online sales of Mike Tyson-branded Iron Energy click here

    Nemaura Medical Inc (NASDAQ:NMRD) makes second management appointment of the week, naming Thomas Mortensen as head of EU commercial operations and marketing click here

    About Proactive

    With six offices on three continents and a team of experienced business journalists and broadcasters, Proactive works with innovative growth companies quoted on the world’s major stock exchanges, helping executives engage intelligently with investors.

    Proactive’ s platform delivers the right message to the right audience, digitally and in real time, leveraging a range of media, investment research, digital investor targeting and website development services to support over 1,000 fast-growing companies globally.

    Proactive’s network reaches over 12 million engaged private, professional and institutional investors looking for opportunities.

    •           Our written and video content is published on Proactive sites that collectively attract up to 10 million views per month.

    •           We syndicate our content to hundreds of mainstream and specialist news sites that expand our reach into networks that can be difficult for press releases to penetrate.

    •           We custom build corporate websites from the ground up, empowering clients and their brands with a modern online presence and the latest insight on effective SEO strategy.

    •           Our news coverage ranks high on the world’s most popular search platforms, and we can further amplify online presence and outreach with sophisticated digital investor targeting.  

    •           We help the world understand what makes companies stand out from the crowd with in-depth investment research from a team of experienced analysts.

    For more information on how Proactive can help you make a difference, email us at [email protected]


    Get the next $NMRD alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $NMRD

    DatePrice TargetRatingAnalyst
    3/29/2022$12.00Buy
    H.C. Wainwright
    12/2/2021$7.50Buy
    EF Hutton
    More analyst ratings

    $NMRD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Ghadar-Ghadr Arash bought $14,000 worth of shares (100,000 units at $0.14) (SEC Form 4)

      4 - Nemaura Medical Inc. (0001602078) (Issuer)

      1/9/24 5:30:57 PM ET
      $NMRD
      Medical/Dental Instruments
      Health Care
    • SEC Form 3 filed by new insider Ghadar-Ghadr Arash

      3 - Nemaura Medical Inc. (0001602078) (Issuer)

      1/9/24 5:29:16 PM ET
      $NMRD
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Natha Salim

      4 - Nemaura Medical Inc. (0001602078) (Issuer)

      2/1/22 4:13:05 PM ET
      $NMRD
      Medical/Dental Instruments
      Health Care

    $NMRD
    SEC Filings

    See more
    • Nemaura Medical Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Nemaura Medical Inc. (0001602078) (Filer)

      9/26/24 9:21:38 AM ET
      $NMRD
      Medical/Dental Instruments
      Health Care
    • SEC Form DEF 14C filed by Nemaura Medical Inc.

      DEF 14C - Nemaura Medical Inc. (0001602078) (Filer)

      7/1/24 7:59:03 AM ET
      $NMRD
      Medical/Dental Instruments
      Health Care
    • SEC Form NT 10-K filed by Nemaura Medical Inc.

      NT 10-K - Nemaura Medical Inc. (0001602078) (Filer)

      7/1/24 7:00:02 AM ET
      $NMRD
      Medical/Dental Instruments
      Health Care

    $NMRD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Ghadar-Ghadr Arash bought $14,000 worth of shares (100,000 units at $0.14) (SEC Form 4)

      4 - Nemaura Medical Inc. (0001602078) (Issuer)

      1/9/24 5:30:57 PM ET
      $NMRD
      Medical/Dental Instruments
      Health Care

    $NMRD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • H.C. Wainwright initiated coverage on Nemaura Medical with a new price target

      H.C. Wainwright initiated coverage of Nemaura Medical with a rating of Buy and set a new price target of $12.00

      3/29/22 7:19:31 AM ET
      $NMRD
      Medical/Dental Instruments
      Health Care
    • EF Hutton initiated coverage on Nemaura Medical with a new price target

      EF Hutton initiated coverage of Nemaura Medical with a rating of Buy and set a new price target of $7.50

      12/2/21 8:50:25 AM ET
      $NMRD
      Medical/Dental Instruments
      Health Care

    $NMRD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CRAIG D. LINDER SELECTED TO 2024 TOP 50 LAWYERS IN AMERICA

      WEST PALM BEACH, Fla., April 11, 2024 /PRNewswire/ --   Anthony, Linder & Cacomanolis, PLLC is proud to announce that Partner Craig D. Linder has been selected to the 2024 Top 50 Lawyers in America list for securities law. This prestigious accolade is part of the 10th annual list honoring a select group of 50 lawyers who have demonstrated outstanding leadership and success within the securities law community in the Americas. America's Top 50 Lawyers identifies and highlights the accomplishments of the nation's most distinguished and skilled attorneys in all fields of practice of law. Only 50 lawyers in each state will receive this honor and be selected for this esteemed membership. This hon

      4/11/24 10:00:00 AM ET
      $FUBO
      $HOUR
      $HTCR
      $MOBQ
      Movies/Entertainment
      Consumer Discretionary
      Catalog/Specialty Distribution
      EDP Services
    • Important Update on Listing Status and Strategic Direction

      Loughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. ("Nemaura Medical" or the "Company"), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs, is providing a crucial update regarding recent decisions that will impact Nemaura Medical's listing status on The Nasdaq Capital Market and our broader strategic direction. Background: After thorough analysis, Nemaura Medical's Board of Directors and management team have made the strategic decision to accept Nasdaq's determination to delist Nemaura Medical and move to the OTC Markets. This decision arises from a careful consideration of several factors, including challenges outside of our cont

      1/3/24 7:00:00 AM ET
      $NMRD
      Medical/Dental Instruments
      Health Care
    • Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision

      Loughborough, UK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ:NMRD) ("Nemaura Medical" or the "Company"), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce that the Nasdaq Hearings Panel granted the Company's request for continued listing pursuant to an exception, including certain interim milestones, that ultimately expires on April 1st, 2024, to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market. The Company plans to continue with its commercial endeavours while pursuing its plans to ensure timely compliance with the terms of the Nasdaq Hearing Panel's decision

      12/13/23 8:00:00 AM ET
      $NMRD
      Medical/Dental Instruments
      Health Care

    $NMRD
    Financials

    Live finance-specific insights

    See more
    • Nemaura Medical, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

      ORLANDO, FL / ACCESSWIRE / November 4, 2022 / RedChip Companies will air a new interview with Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, on The RedChip Money Report® on Bloomberg TV, this Saturday, November 5, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Interview highlights:In the exclusive RedChip Money Report interview, Nemaura's CEO Dr. Faz Chowdhury discusses Nemaura's continuous glucose sensor, the sugarBEAT®, its potential impact on the 500

      11/4/22 8:00:00 AM ET
      $NMRD
      Medical/Dental Instruments
      Health Care
    • Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022

      Loughborough, England, June 30, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, today provides a business update and releases its financial results for the fiscal year ended March 31, 2022. Corporate Highlights for FY2022: Commenced shipments of sugarBEAT® continuous glucose monitor (CGM) devices to its UK licensee, MySugarWatch Limited ("MSWL"), previously DB Ethitronix Limited. MSWL commenced mass educational and awareness campaigns to physicians in the UK via a

      6/30/22 8:00:00 AM ET
      $NMRD
      Medical/Dental Instruments
      Health Care
    • Nemaura Medical Reports Financial Results and Provides Business Update for the First Fiscal Quarter Ended June 30, 2021

      Loughborough, England, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today provides a business update and releases its financial results for the first fiscal quarter, ended June 30, 2021, of fiscal 2022. Recent Corporate Highlights: Launched a digital healthcare subscription service in the U.S. under the brand name BEAT®diabetes, targeted at over 25 million people with Type 2 diabetes and 88 million people with pre-diabetes in the U.S.Received positive feedback fro

      8/16/21 8:30:00 AM ET
      $NMRD
      Medical/Dental Instruments
      Health Care

    $NMRD
    Leadership Updates

    Live Leadership Updates

    See more
    • Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.

      LOUGHBOROUGH, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercialising non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced the appointment of Nikolai Rozanov as strategic adviser in AI development. Mr Rozanov is a specialist in the field of artificial intelligence and was selected for inclusion by Forbes magazine in their '30 Under 30' list in the field of technology, a prestigious honour accorded to the best up-and-coming talent in the sector. The appointment of Mr Rozanov solidifies the Company's expertise in

      9/26/23 9:50:00 AM ET
      $NMRD
      Medical/Dental Instruments
      Health Care
    • Nemaura Medical Appoints Dr. Arash Ghadar as Chief Operating Officer

      Loughborough, England, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD)("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces the appointment of Dr. Arash (Ash) Ghadar as Chief Operating Officer. "Ash will play an important role at Nemaura as we begin to scale up our manufacturing and distribution operations. He brings over 20 years of product development, management and leadership experience spanning both business and technical disciplines. His main area of expertise is in the medical devices sector, and primarily w

      1/10/22 8:00:00 AM ET
      $NMRD
      Medical/Dental Instruments
      Health Care
    • Nemaura Medical Appoints Samantha Sanders as Global Head of Digital Programs

      Loughborough, England, April 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced the appointment of Samantha Sanders as its Global Head of Digital Programs. Samantha has over two decades of project development, management and customer service experience, delivering successful digital projects to market within the wellbeing, pharmaceutical and medical device sector, both locally and internationally.  Prior to joining the Nemaura team, more recently Samantha has bee

      4/15/21 8:07:00 AM ET
      $NMRD
      Medical/Dental Instruments
      Health Care

    $NMRD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Nemaura Medical Inc.

      SC 13G - Nemaura Medical Inc. (0001602078) (Subject)

      2/14/24 1:54:39 PM ET
      $NMRD
      Medical/Dental Instruments
      Health Care